Iranian HPV Vaccine Remains Accessible: Clarifying Distribution Channels
Following recent speculation regarding the availability of domestically produced human papillomavirus (HPV) vaccines in Iran, an on-the-ground survey of Tehran pharmacies confirms that the vaccines continue to be readily accessible to the public.
Streamlining the Market
Reports of a market withdrawal pertained to one of two domestic manufacturing companies. The vaccine currently available is produced by a knowledge-based Iranian company under the brand name Gardasil. This strategic focus on a single, vetted product ensures consistent quality and availability for citizens at a price point significantly lower than that of foreign alternatives.
A Critical Public Health Priority
Health experts emphasize the critical importance of HPV vaccination, noting the virus’s link to cervical, anal, and other cancers. Vaccination is universally recognized as the primary method for preventing these diseases. The available quadrivalent Iranian vaccine provides robust coverage against the most common and high-risk strains of the virus, aligning with global health standards for prevention.
Confirmed Availability and Public Guidance
A central Tehran pharmacy confirmed the vaccine’s availability, stating, “The vaccine is in stock at the pharmacy, and citizens can come to receive it.”
Medical professionals recommend vaccination during adolescence, prior to potential exposure to the virus. However, they also advise that adults who have not previously been vaccinated can still receive the shot after consulting with a physician, highlighting the ongoing importance of the immunization program.
